Tonix pharma Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Tonix pharma Contact Number

Contact :: Tonix Pharmaceuticals Holding Corp. (TNXP)

5 hours ago Tonixpharma.com Show details

(212) 980-9155Thank you for your interest in learning more about Tonix. We look forward to hearing from you. Tonix Pharmaceuticals Holding Corp. New Jersey Office (Corporate Headquarters) 26 Main Street Suite 101 Chatham, NJ 07928 [email protected] New York Office 509 Madison Avenue Suite 1608 New York, NY 10022 (212) 980-9155 (phone)

Category: Contact SupportShow more

Tonix Pharmaceuticals Holding Corp. (TNXP)

8 hours ago Tonixpharma.com Show details

Contact; Improving the Landscape. Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) (Tonix) is a clinical-stage biopharmaceutical company committed to discovering and developing innovative and proprietary new therapeutics that address the needs of patients. We focus on developing small molecules and biologics to treat CNS (pain, neurology

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Crunchbase Company …

9 hours ago Crunchbase.com Show details

212-980-9155Contact Email [email protected] Phone Number 212-980-9155. Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of central nervous system (CNS) and

Founded: 2007
Founder: Seth Lederman

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Corp. Company Profile

8 hours ago Dnb.com Show details

Tonix Pharmaceuticals Holding Corp. is located in Chatham, NJ, United States and is part of the Pharmaceutical and Medicine Manufacturing Industry. Tonix Pharmaceuticals Holding Corp. has 26 total employees across all of its locations and generates $7.26 million in …

Employees: 7
Total Assets: $14.56
Tangible Fixed Assets: $0.39
Location: 509 Madison Ave Rm 1608, New York, 10022-5534, NY

Category: Contact NumberShow more

TONIX PHARMACEUTICALS HOLDING CORP. :: New York …

Just Now Opencorporates.com Show details

Free and open company data on New York (US) company TONIX PHARMACEUTICALS HOLDING CORP. (company number 4165696), 25 ROBERT PITT DRIVE, SUITE 204, MONSEY, NEW YORK, 10952 Learn how to leverage transparent company data at scale.

Category: Contact NumberShow more

Tonix Pharmaceuticals Company Profile Office Locations

8 hours ago Craft.co Show details

Tonix to Present Posters on TNX-102 SL for Fibromyalgia and PTSD CHATHAM, N.J., May 26, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company) a clinical-stage biopharmaceutical company, announced that it will present two posters at the 2021 American So…

Category: Contact NumberShow more

Management Team :: Tonix Pharmaceuticals Holding …

8 hours ago Tonixpharma.com Show details

In addition, he has served as Tonix’s Chief Medical Officer from 2009 to 2011 and for other early-stage companies that include Vela Pharmaceuticals, Validus Pharmaceuticals. Dr. Harris served on the Scientific Advisory Board of Tonix for approximately 10 years until his appointment as Tonix’s Executive Vice President, Translational Medicine.

Category: Contact NumberShow more

Tonix Pharmaceuticals Announces FDA Clearance of the …

3 hours ago Tonixpharma.com Show details

Tonix’s lead vaccine candidate for COVID-19, TNX-1800 3, is a live replicating vaccine based on Tonix’s recombinant pox vaccine (RPV) platform to protect against COVID-19, primarily by eliciting a T cell response. Tonix expects to start a Phase 1 study in humans in the second half of 2022.

Category: Contact NumberShow more

Tonix Pharmaceuticals and Massachusetts General …

3 hours ago Tonixpharma.com Show details

Tonix Pharmaceuticals Holding Corp. Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of central nervous system (CNS) and immunology product candidates.

Category: Contact NumberShow more

Tonix Pharmaceuticals Email Format tonixpharma.com …

4 hours ago Rocketreach.co Show details

Tonix Pharmaceuticals Email Format. Tonix Pharmaceuticals uses 2 email formats, with first '.' last (ex. [email protected]) being used 92.9% of the time. Get Verified Emails for Tonix Pharmaceuticals Employees. Tonix Pharmaceuticals's Email Format. Percentage.

Category: Contact NumberShow more

TNXP Insider Trading Report Tonix Pharmaceuticals

7 hours ago Fintel.io Show details

08-09 sec.gov - Tonix Pharmaceuticals Holding Corp. 8-K Exhibit 99.01 Tonix Pharmaceuticals Reports Second Quarter 2021 Financial Results and Operational Highlights Central Nervous System Pipeline Progressing with Two Phase 2 Studies (TNX-1300 and TNX-1900) and One Phase 3 Study (TNX-102 SL) Expected to Start This Year COVID-19 Pipeline

Category: Contact NumberShow more

Tonix Pharmaceuticals Announces Publication of Paper on

5 hours ago Finance.yahoo.com Show details

CHATHAM, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the

Category: Contact NumberShow more

Press Releases :: Tonix Pharmaceuticals Holding Corp. (TNXP)

3 hours ago Ir.tonixpharma.com Show details

CHATHAM, N.J., Nov. 22, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the publication of “ Sangivamycin is highly effective against SARS-CoV-2 in vitro and has favorable drug properties, ” in JCI Insight.

Category: Contact NumberShow more

Overview :: Tonix Pharmaceuticals Holding Corp. (TNXP)

7 hours ago Ir.tonixpharma.com Show details

Company Overview. Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat pain, addiction and psychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Tonix's lead product candidate, TNX-102 SL, is in Phase 3 development as

Category: Contact NumberShow more

TONIX PHARMACEUTICALS HOLDING CORP.

6 hours ago Ir.tonixpharma.com Show details

131-20-0061TONIX PHARMACEUTICALS HOLDING CORP. (Exact name of registrant as specified in its charter) Nevada 001-36019 26-1434750 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 509 Madison Avenue, Suite 1608, New York, New York 10022

Category: Contact NumberShow more

Press Releases :: Tonix Pharmaceuticals Holding Corp. (TNXP)

3 hours ago Ir.tonixpharma.com Show details

Tonix expects topline data for the RELIEF study in the fourth quarter of 2020 unless the interim Independent Data Monitoring Committee recommends an increase in the total number of participants. Tonix plans to initiate a second potentially pivotal Phase 3 trial, F306 or the RALLY study, to study TNX-102 SL for the management of fibromyalgia.

Category: Contact NumberShow more

TNXP Short Interest Tonix Pharmaceuticals Holding Corp

8 hours ago Fintel.io Show details

05-14 sec.gov - Tonix Pharmaceuticals Holdings Group 8-K Exhibit 5.01 May 14, 2021 Tonix Pharmaceuticals Holding Corp. 26 Main Street, Suite 101 Chatham, New Jersey 07928 Ladies and Gentlemen: We have acted as local Nevada counsel to Tonix Pharmaceuticals Holding Corp., a Nevada corporation (the “Company”), in connection with the issuance

Category: Contact NumberShow more

More Than Vaccines: Tonix Programs Address the Spectrum of

3 hours ago Benzinga.com Show details

Tonix Pharmaceuticals (NASDAQ: TNXP) is one of the few companies pursuing vaccines and therapeutics that address the spectrum of Covid-19 needs ranging from prevention to …

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Corp. (TNXP) 10K Annual

6 hours ago Last10k.com Show details

Tonix Pharmaceuticals Holding Corp. (TNXP) SEC Filing 10-K Annual report for the fiscal year ending Thursday, December 31, 2020. Home SEC Filings Tonix Pharmaceuticals Holding Corp. (TNXP) 10-K Annual Report Mon Mar 15 2021. 10-K Annual Report Summary. 10-K Annual Report. 10-K YoY Changes.

Category: Contact NumberShow more

Press Releases :: Tonix Pharmaceuticals Holding Corp. (TNXP)

Just Now Ir.tonixpharma.com Show details

Contact; News / Press Releases : Press Releases. About Tonix Pharmaceuticals Holding Corp. Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. There are a number of factors that could

Category: Contact NumberShow more

Tonix Pharmaceuticals Issues Letter to Shareholders

1 hours ago News.yahoo.com Show details

Tonix Pharmaceuticals Holding Corp. (TONIX) has made significant progress in nearly every aspect of its business since becoming a publicly-traded company in October 2011, and I am pleased to report on some of these corporate achievements in this letter.

Category: Contact NumberShow more

Tonix Pharmaceuticals to Present at the H.C. Wainwright

9 hours ago Finance.yahoo.com Show details

The information set forth herein speaks only as of the date thereof. Jessica Morris (corporate) Tonix Pharmaceuticals. [email protected]

Category: Contact NumberShow more

Tonix Pharmaceuticals Plans Vaccine Development and

3 hours ago Sterlingcreadvisors.com Show details

Tonix in Hamilton. About Tonix Pharmaceuticals. Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company committed to discovering and developing new therapeutics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of central nervous system (CNS) and immunology product

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Corp. BIOEurope

1 hours ago Informaconnect.com Show details

Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067. Save the date for next year! October 24–26, Tonix Pharmaceuticals Holding Corp. Contact. www.tonixpharma.com. Meet Tonix Pharmaceuticals Holding Corp.

Category: Contact NumberShow more

Tonix Pharmaceuticals Enters into Exclusive Worldwide

4 hours ago Finance.yahoo.com Show details

Contacts Tonix Pharmaceuticals InquiriesOyaGen, Inc. Inquiries Jessica Morris (corporate)Kevin J. PhelpsTonix PharmaceuticalsCFO, OyaGen, [email protected]@oyageninc

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Number of Employees 2009

6 hours ago Macrotrends.net Show details

Tonix Pharmaceuticals Holding number of employees from 2009 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Contact NumberShow more

Tonix Pharmaceuticals Announces Agreement to Acquire

5 hours ago Finance.yahoo.com Show details

CHATHAM, N.J., July 27, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing

Category: Contact NumberShow more

Tonix Pharmaceuticals Wikipedia

1 hours ago En.wikipedia.org Show details

Tonix Pharmaceuticals (Tonix Pharmaceuticals Holding Corp.) is a pharmaceutical company based in Chatham, New jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project.

Category: Contact NumberShow more

Tonix Pharmaceuticals Announces Completion of Acquisition

Just Now Finance.yahoo.com Show details

CHATHAM, N.J., Oct. 04, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced it has completed

Category: Contact NumberShow more

Tonix Pharmaceuticals : R&D Facility in Frederick, MD is

Just Now Marketscreener.com Show details

CHATHAM, N.J., July 27, 2021 - Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced the signing of a Purchase and Sale Agreement to acquire an approximately 48,000 square foot research and development (R&D) facility in Frederick, MD to support Tonix's expanding

Category: Contact NumberShow more

$TNXP is a penny stock that can be a game changer in this

2 hours ago Reddit.com Show details

Tonix Pharmaceuticals’ recombinant vaccine is a live attenuated replicating vaccine, TNX-1800. The only other live virus with as much promise is by Codagenix, Covi-Vac, an attenuated whole virus that’s internasal delivery but CDX is not traded yet. These are both Generation 2 vaccines and because they are live virus vaccines, they are

Category: Contact NumberShow more

TNXP Stock Forecast, Price & News (Tonix Pharmaceuticals)

6 hours ago Marketbeat.com Show details

212-980-9155

1. Tonix Pharmaceuticals' mailing address is 509 MADISON AVE SUITE 306, NEW YORK NY, 10022. The company can be reached via phone at 212-980-9155 or via email at [email protected]

Category: Contact NumberShow more

Current Report Filing (8k)

3 hours ago Ih.advfn.com Show details

(862) 904-818226 Main Street, Chatham, New Jersey 07928 (Address of principal executive offices) (Zip Code) Registrant’s telephone number, including area code: (862) 904-8182 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Category: Contact NumberShow more

Tonix Pharmaceuticals Announces Research Collaboration

5 hours ago Cnn.com Show details

Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 …

Category: Contact NumberShow more

Tonix Pharmaceuticals Total Employees (Annual) TNXP

6 hours ago Ycharts.com Show details

Tonix Pharmaceuticals Announces Ribbon-Cutting Ceremony for its Infectious Disease R&D Center in Maryland Globe Newswire 10/15 07:00 ET New to The Street T.V. Announces Four T.V. Interviews Being Broadcasted on Fox Business Network, Tonight, Thursday, October 14, 2021, at …

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Corp. (TNXP) Stock Guide

1 hours ago Askfinny.com Show details

Here are the reasons to buy TNXP stock: TNXP stock price ($0.73) is close to the 52-week low ($0.66). Perhaps now is a good time to buy? See TNXP price chart. TNXP Price/Book ratio is 1.29, which is low compared to its industry peers’ P/B ratios. See TNXP forward Price/Book ratio chart.

Category: Contact NumberShow more

Tonix Pharmaceuticals Regains Compliance with Nasdaq

7 hours ago Apnews.com Show details

Tonix Pharmaceuticals Holding Corp. March 4, 2021 GMT CHATHAM, N.J., March 04, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that it has regained compliance with the minimum bid price requirement for continued listing on The Nasdaq

Category: Contact NumberShow more

NEW: Priceestimate has been released for $TNXP – The Wall

5 hours ago Wallstreetfacts.com Show details

The 52-week high for Tonix Pharmaceuticals Holding Corp is $2.12 and the low is $0.46. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Presents

8 hours ago Biopharmajournal.com Show details

Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has given an oral presentation of encouraging results from the Phase 3 clinical study, RELIEF evaluating its TNX-102 SL for fibromyalgia treatment. Tonix announces positive results of Phase 3 RELIEF trial of TNX-102 SL. The presentation by Tonix Chief Medical Officer Gregory Sullivan was titled, “TNX-102 SL (Sublingual Cyclobenzaprine) …

Category: Contact NumberShow more

Tonix Pharmaceuticals Stock Price Target and Analyst

1 hours ago Pricetargets.com Show details

(212) 980-9155Tonix Pharmaceuticals' physical mailing address is 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022. The company's listed phone number is (212) 980-9155 and its investor relations email address is [email protected] The official website for Tonix Pharmaceuticals is www.tonixpharma.com.

Category: Contact NumberShow more

UPDATED: $TNXP has a new price prediction – The Wall

9 hours ago Wallstreetfacts.com Show details

The 52-week high for Tonix Pharmaceuticals Holding Corp is $2.12 and the low is $0.51. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

This Is A Time To Invest In Tonix Pharmaceuticals Holding

6 hours ago Marketingsentinel.com Show details

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP)’s traded shares stood at 5.52 million during the latest session, with the company’s beta value hitting 1.16. At the last check today, the stock’s price was $0.49, to imply a decrease of -2.06% or -$0.02 in intraday trading. The TNXP share’s 5

Category: Contact NumberShow more

Tonix Pharmaceuticals to Present at the Q4 Investor Summit

1 hours ago Biospace.com Show details

CHATHAM, N.J., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, today announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present at the Q4 Investor Summit on November 17, 2021, at 4:50 p.m. ET.

Category: Contact NumberShow more

Should You Buy Tonix Pharmaceuticals Holding Corp (TNXP

Just Now Investorsobserver.com Show details

Tonix Pharmaceuticals Holding Corp (Tonix Pharmaceuticals Holding Corp ()) is up Tuesday morning, with the stock rising 17.42% in pre-market trading to 1.82.TNXP's short-term technical score of 84 indicates that the stock has traded more bullishly …

Category: Contact NumberShow more

TONIX PHARMACEUTICALS HOLDING CORP. : TNXP Stock Price

8 hours ago Marketscreener.com Show details

Tonix Pharmaceuticals Holding Corp. (Tonix) is a clinical-stage biopharmaceutical company. The Company is focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonixs portfolio is primarily composed of immunology and central nervous system (CNS

Category: Contact NumberShow more

Tonix Pharmaceuticals hiring Process Engineer II in New

Just Now Linkedin.com Show details

Posted 9:44:39 PM. About Tonix:Tonix is a global biopharmaceutical company, publicly traded on NASDAQ (ticker:…See this and similar jobs on LinkedIn.

Category: Contact NumberShow more

Tonix Pharmaceuticals hiring Director, CMC Virtual Project

Just Now Linkedin.com Show details

Tonix Pharmaceuticals United States. Apply Now Director, CMC Virtual Project Management. Tonix Pharmaceuticals United States Just now Be among the first 25 applicants

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What is Tonix Pharmaceuticals' mailing address?

Tonix Pharmaceuticals' physical mailing address is 509 MADISON AVENUE SUITE 1608, NEW YORK NY, 10022. The company's listed phone number is 212-980-9155 and its investor relations email address is [email protected] The official website for Tonix Pharmaceuticals is www.tonixpharma.com.

Who is tontonix pharmaceuticals?

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, discovers, acquires, develops, and licenses small molecules and biologics to treat and prevent human diseases and alleviate suffering.

When is Tonix Pharmaceuticals' next quarterly earnings announcement?

Tonix Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021. View our earnings forecast for Tonix Pharmaceuticals. How were Tonix Pharmaceuticals' earnings last quarter?

What does Tonix do?

Tonix is a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat serious neuropsychiatric conditions and biological products to improve biodefense through potential medical counter-measures. Tonix is developing Tonmya®*, which is in Phase 3 development as...

Popular Brands

Tsmc
Tesla
Tata
Toyota
Tesco
Tgs
Tui